A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study

Launched by POWER LIFE SCIENCES INC. · Oct 6, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the experiences of patients with medullary thyroid cancer, a specific type of thyroid cancer. The main goal is to see how many people complete the study and if anyone decides to leave the study voluntarily. By participating, patients can help researchers learn more about the safety and effectiveness of new treatments compared to standard therapies, which could lead to better care for others with this condition.

To be eligible for this study, participants must be at least 18 years old and have a confirmed diagnosis of medullary thyroid cancer. They should also be in good health overall, without any serious medical or mental health issues that could affect their participation. Pregnant or breastfeeding individuals, or those taking other experimental drugs, cannot join. While the study is not yet recruiting participants, those who take part can expect to contribute valuable information that may help improve treatment options for medullary thyroid cancer in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed diagnosis of medullary thyroid cancer
• • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• • No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
• Exclusion Criteria:
• • Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• • Any serious and/or unstable pre-existing medical disorders
• • Patients who are currently receiving any other investigational drug.